肿瘤细胞治疗研究
ALL SOURCES
Injectable Hydrogels for Breast Cancer Therapy: From Tumor Microenvironment-Responsive and Actively Targeted Drug Delivery to Immunotherapy and Theran
乳腺癌治疗仍面临诸多挑战，包括局部复发、全身毒性、肿瘤异质性、耐药和免疫抑制。
A review of soluble mediator and cytokine networks linking combination immunotherapy, tumor microenvironment remodeling and skeletal muscle dysfunctio
联合免疫疗法彻底改变了晚期恶性肿瘤的临床管理，但其显著的抗肿瘤疗效常常因治疗诱发的骨骼肌功能障碍而受损，这种功能障碍由连接肿瘤微环境（TME）与外周肌肉区室的相互信号回路所调控。
Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review.
背景/目的：免疫检查点是维持外周耐受和防止自身免疫的关键调控通路。
Clinical landscape and development of universal CAR-T cell therapies.
Viral and non-viral vectors in gene therapy: current state and clinical perspectives.
基因治疗的进步在治疗人类疾病方面取得了重要里程碑，为选择有限的患者带来了新的希望。
Harnessing exosomes: From tumor immune escape to therapeutic innovation in gastric cancer immunotherapy.
胃癌在全球最常见癌症中排名第五，预后不佳。
Application of CAR-T therapy in solid tumors: current opportunities and challenges.
近年来，CAR-T 细胞疗法在治疗血液系统恶性肿瘤方面取得了实质性进展。
Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate can
我们的研究表明，在结合CAR-T细胞疗法治疗前列腺癌时，有必要平衡ZOL的贡献。
Barriers and solutions for CAR-T therapy in solid tumors.
嵌合抗原受体（CAR）-T细胞疗法已成为一种变革性的癌症治疗方法，尤其在血液系统恶性肿瘤中。
Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology-based strategies for enhanced CAR T/
胶质母细胞瘤是全球中枢神经系统恶性肿瘤领域的一大挑战。
MEMBER ACCOUNT
登录成功会直接打开下一页。
